Tuberculosis (TB) vaccine mainly acts as a preventive measure against this infectious disease caused by bacteria called Mycobacterium tuberculosis. TB vaccine helps boost the immune system to fight against TB infection. Vaccination plays an important role in controlling and eventually eliminating TB from the population. Currently, only one vaccine Bacillus Calmette-Guérin (BCG) vaccine is available for preventing childhood TB, which is less effective in preventing adult pulmonary TB. The global Tuberculosis Vaccine Market is estimated to be valued at US$ 149.67 Mn in 2023 and is expected to exhibit a CAGR of 21% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Opportunity:
Rising awareness on preventive measures for tuberculosis, especially in developing nations is estimated to offer high growth opportunity for tuberculosis vaccine market over the forecast period. Introduction of more effective TB vaccine and prevention programs focusing on controlling TB infection can significantly contribute to reduction in disease burden. Development of vaccines targeting adult pulmonary TB with improved efficacy can boost the market growth substantially. Increasing research activities for novel TB vaccine development and funding from public-private organizations indicate positive market outlook. Introduction of vaccines preventing all forms of TB with long-lasting protective immune responses will drive the tuberculosis vaccine market growth during the forecast period.
Porter's Analysis
Threat of new entrants: The threat of new entrants in the tuberculosis vaccine market is moderate as it requires huge investments and long periods of clinical trials for new vaccine development. However, increase in prevalence of tuberculosis globally has attracted many companies.
Bargaining power of buyers: Buyers have moderate bargaining power due to availability of substitutes and existence of many players. However, growing awareness and initiatives by governments towards eradicating tuberculosis boosts demand.
Bargaining power of suppliers: Suppliers have moderate bargaining power due to dependence of manufacturers on raw material suppliers and established supplier relationships.
Threat of new substitutes: Threat of new substitutes is low as existing vaccines are effective against tuberculosis and newer therapies take years of research and clinical testing.
Competitive rivalry: Intense as major players compete on basis of efficacy, safety profile, patent protection and geographic expansion.
SWOT Analysis
Strengths: Existing vaccines have proven efficacy and safety. Growing government support and initiatives favor market growth.
Weaknesses: Low adoption in low and middle income countries due to high costs. Supply chain and logistical challenges in remote areas.
Opportunities: Increasing global fund allocation by WHO. Focus on development of low cost vaccines, new delivery methods.
Threats: Emergence of drug resistant strains poses risks. Stringent regulations for approval delays new products launch.
Key Takeaways
The global tuberculosis vaccine market scope is expected to witness high growth during the forecast period of 2023-2030.
Regional analysis: Asia Pacific is poised to grow at fastest pace led by India and China on back of huge patient population, growing health awareness and government support. However, access challenges in remote areas and low adoption in low income nations hinders market growth.
Key players: Key players operating in the Tuberculosis Vaccine market are Fujitsu Limited, Mindtree Limited, IBM Corporation, Wipro Limited, Unisys Corporation, CenturyLink Inc., Virtustream Inc. and HCL Technologies Limited. Major players focus on strengthening their distribution networks and developing affordable dosing and delivery options to tap opportunities in emerging countries.
Get more insights on this topic: https://www.trendingwebwire.com/tuberculosis-vaccine-market-industry-insights-trends-tuberculosis-vaccine-market/
Explore more information on this topic, Please visit: https://wotpost.com/optical-transceivers-enabling-high-speed-data-transmission/
This report contains market size and forecasts of Tuberculosis Vaccine Treatment in global, including the following market information: Global Tuberculosis Vaccine Treatment Market Revenue, 2016-2021, 2022-2027, ($ millions) Global Tuberculosis Vaccine Treatment Market Sales, 2016-2021, 2022-2027, (K Dose) Global top five Tuberculosis Vaccine Treatment companies in 2020 (%) The global Tuberculosis Vaccine Treatment market was valued at 74 million in 2020 and is projected to reach US$ 83 million by 2027, at a CAGR of 2.8% during the forecast period.
We surveyed the Tuberculosis Vaccine Treatment manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment: Global Tuberculosis Vaccine Treatment Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Dose) Global Tuberculosis Vaccine Treatment Market Segment Percentages, By Type, 2020 (%) Immune Vaccine Therapy VaccineGlobal Tuberculosis Vaccine Treatment Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Dose) Global Tuberculosis Vaccine Treatment Market Segment Percentages, By Application, 2020 (%) Self-Procurement UNICEF OtherDownload FREE Sample of this Report @ https://www.statsmarketresearch.com/download-free-sample/6567681/global-tuberculosis-vaccine-treatment-market-2021-2027-925 Global Tuberculosis Vaccine Treatment Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Dose) Global Tuberculosis Vaccine Treatment Market Segment Percentages, By Region and Country, 2020 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Tuberculosis Vaccine Treatment revenues in global market, 2016-2021 (Estimated), ($ millions) Key companies Tuberculosis Vaccine Treatment revenues share in global market, 2020 (%) Key companies Tuberculosis Vaccine Treatment sales in global market, 2016-2021 (Estimated), (K Dose) Key companies Tuberculosis Vaccine Treatment sales share in global market, 2020 (%) Further, the report presents profiles of competitors in the market, key players include: Merck Japan BCG Lab Serum Institute of India AJ Vaccines BioFarma GreenSignal Bio Pharma China National Biotec Biomed Lublin Taj Pharmaceuticals Ataulpho de Paiva IVAC Queen Saovabha Mem.
Inst MicrogenGet the Complete Report & TOC @ https://www.statsmarketresearch.com/global-tuberculosis-vaccine-treatment-market-2021-2027-925-6567681Table of content1 Introduction to Research & Analysis Reports1.1 Tuberculosis Vaccine Treatment Market Definition1.2 Market Segments1.2.1 Market by Type1.2.2 Market by Application1.3 Global Tuberculosis Vaccine Treatment Market Overview1.4 Features & Benefits of This Report1.5 Methodology & Sources of Information1.5.1 Research Methodology1.5.2 Research Process1.5.3 Base Year1.5.4 Report Assumptions & Caveats2 Global Tuberculosis Vaccine Treatment Overall Market Size2.1 Global Tuberculosis Vaccine Treatment Market Size: 2021 VS 20272.2 Global Tuberculosis Vaccine Treatment Revenue, Prospects & Forecasts: 2016-20272.3 Global Tuberculosis Vaccine Treatment Sales (Consumption): 2016-20273 Company Landscape3.1 Top Tuberculosis Vaccine Treatment Players in Global Market3.2 Top Global Tuberculosis Vaccine Treatment Companies Ranked by Revenue3.3 Global Tuberculosis Vaccine Treatment Revenue by Companies3.4 Global Tuberculosis Vaccine Treatment Sales by Companies3.5 Global Tuberculosis Vaccine Treatment Price by Manufacturer (2016-2021)3.6 Top 3 and Top 5 Tuberculosis Vaccine Treatment Companies in Global Market, by Revenue in 20203.7 Global Manufacturers Tuberculosis Vaccine Treatment Product Type3.8 Tier 1, Tier 2 and Tier 3 Tuberculosis Vaccine Treatment Players in Global Market3.8.1 List of Global Tier 1 Tuberculosis Vaccine TreCONTACT US:New York City Zone 01, United StatesInternational: (+1) 646 781 7170Email: [email protected]
